Table of Contents

1 Study Coverage

• 1.1 NSAIDs Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global NSAIDs Market Size Growth Rate by Product
  • 1.4.2 Aspirin
  • 1.4.3 Ibuprofen
  • 1.4.4 Naproxen
  • 1.4.5 Nabumetone
  • 1.4.6 Others
• 1.5 Market by End User
  • 1.5.1 Global NSAIDs Market Size Growth Rate by End User
  • 1.5.2 Back Pain Treatment
  • 1.5.3 Osteoarthritis Treatment
  • 1.5.4 Other Disease Treatment
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global NSAIDs Market Size
  • 2.1.1 Global NSAIDs Revenue 2014-2025
  • 2.1.2 Global NSAIDs Sales 2014-2025
• 2.2 NSAIDs Growth Rate by Regions
  • 2.2.1 Global NSAIDs Sales by Regions
  • 2.2.2 Global NSAIDs Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 NSAIDs Sales by Manufacturers
  • 3.1.1 NSAIDs Sales by Manufacturers
  • 3.1.2 NSAIDs Sales Market Share by Manufacturers
  • 3.1.3 Global NSAIDs Market Concentration Ratio (CR5 and HHI)
• 3.2 NSAIDs Revenue by Manufacturers
  • 3.2.1 NSAIDs Revenue by Manufacturers (2014-2019)
  • 3.2.2 NSAIDs Revenue Share by Manufacturers (2014-2019)
• 3.3 NSAIDs Price by Manufacturers
• 3.4 NSAIDs Manufacturing Base Distribution, Product Types
  • 3.4.1 NSAIDs Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers NSAIDs Product Type
  • 3.4.3 Date of International Manufacturers Enter into NSAIDs Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global NSAIDs Sales by Product
• 4.2 Global NSAIDs Revenue by Product
• 4.3 NSAIDs Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global NSAIDs Breakdown Data by End User

6 North America

• 6.1 North America NSAIDs by Countries
  • 6.1.1 North America NSAIDs Sales by Countries
  • 6.1.2 North America NSAIDs Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America NSAIDs by Product
• 6.3 North America NSAIDs by End User

7 Europe

• 7.1 Europe NSAIDs by Countries
  • 7.1.1 Europe NSAIDs Sales by Countries
  • 7.1.2 Europe NSAIDs Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe NSAIDs by Product
• 7.3 Europe NSAIDs by End User

8 Asia Pacific

• 8.1 Asia Pacific NSAIDs by Countries
  • 8.1.1 Asia Pacific NSAIDs Sales by Countries
  • 8.1.2 Asia Pacific NSAIDs Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific NSAIDs by Product
• 8.3 Asia Pacific NSAIDs by End User

9 Central & South America

• 9.1 Central & South America NSAIDs by Countries
  • 9.1.1 Central & South America NSAIDs Sales by Countries
  • 9.1.2 Central & South America NSAIDs Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America NSAIDs by Product
• 9.3 Central & South America NSAIDs by End User

10 Middle East and Africa

• 10.1 Middle East and Africa NSAIDs by Countries
  • 10.1.1 Middle East and Africa NSAIDs Sales by Countries
  • 10.1.2 Middle East and Africa NSAIDs Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa NSAIDs by Product
• 10.3 Middle East and Africa NSAIDs by End User

11 Company Profiles

• 11.1 Bayer
  • 11.1.1 Bayer Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Bayer NSAIDs Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Bayer NSAIDs Products Offered
  • 11.1.5 Bayer Recent Development
• 11.2 Novacap
  • 11.2.1 Novacap Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Novacap NSAIDs Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Novacap NSAIDs Products Offered
  • 11.2.5 Novacap Recent Development
• 11.3 Abbott
  • 11.3.1 Abbott Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Abbott NSAIDs Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Abbott NSAIDs Products Offered
  • 11.3.5 Abbott Recent Development
• 11.4 Pfizer
  • 11.4.1 Pfizer Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Pfizer NSAIDs Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Pfizer NSAIDs Products Offered
  • 11.4.5 Pfizer Recent Development
• 11.5 Johnson & Johnson
  • 11.5.1 Johnson & Johnson Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Johnson & Johnson NSAIDs Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Johnson & Johnson NSAIDs Products Offered
  • 11.5.5 Johnson & Johnson Recent Development
• 11.6 Cigna
  • 11.6.1 Cigna Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Cigna NSAIDs Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Cigna NSAIDs Products Offered
  • 11.6.5 Cigna Recent Development
• 11.7 Geri-Care Pharmaceuticals
  • 11.7.1 Geri-Care Pharmaceuticals Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Geri-Care Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Geri-Care Pharmaceuticals NSAIDs Products Offered
  • 11.7.5 Geri-Care Pharmaceuticals Recent Development
• 11.8 Perrigo Company
  • 11.8.1 Perrigo Company Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Perrigo Company NSAIDs Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Perrigo Company NSAIDs Products Offered
  • 11.8.5 Perrigo Company Recent Development
• 11.9 Kopran
  • 11.9.1 Kopran Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Kopran NSAIDs Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Kopran NSAIDs Products Offered
  • 11.9.5 Kopran Recent Development
• 11.10 Merck Sharp & Dohme
  • 11.10.1 Merck Sharp & Dohme Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Merck Sharp & Dohme NSAIDs Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Merck Sharp & Dohme NSAIDs Products Offered
  • 11.10.5 Merck Sharp & Dohme Recent Development
• 11.11 Sun Pharmaceutical Industries
• 11.12 GlaxoSmithKline
• 11.13 Reddy Pharmaceuticals
• 11.14 Verywell

12 Future Forecast

• 12.1 NSAIDs Market Forecast by Regions
  • 12.1.1 Global NSAIDs Sales Forecast by Regions 2019-2025
  • 12.1.2 Global NSAIDs Revenue Forecast by Regions 2019-2025
• 12.2 NSAIDs Market Forecast by Product
  • 12.2.1 Global NSAIDs Sales Forecast by Product 2019-2025
  • 12.2.2 Global NSAIDs Revenue Forecast by Product 2019-2025
• 12.3 NSAIDs Market Forecast by End User
• 12.4 North America NSAIDs Forecast
• 12.5 Europe NSAIDs Forecast
• 12.6 Asia Pacific NSAIDs Forecast
• 12.7 Central & South America NSAIDs Forecast
• 12.8 Middle East and Africa NSAIDs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 NSAIDs Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global NSAIDs market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the NSAIDs market based on company, product type, end user and key regions.

This report studies the global market size of NSAIDs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of NSAIDs in these regions.
This research report categorizes the global NSAIDs market by top players/brands, region, type and end user. This report also studies the global NSAIDs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell

Market size by Product
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Market size by End User
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global NSAIDs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of NSAIDs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global NSAIDs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of NSAIDs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of NSAIDs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of NSAIDs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.